Egyptian International Pharmaceutical Industries Co. (PHAR) Key Statistics
26 reported figures for Egyptian International Pharmaceutical Industries Co. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 16.86B
- P/E (trailing)
- 11.23
- P/B
- 2.63
- Dividend yield (FY 2025)
- 3.5%
Income (latest fiscal year)
- Revenue
- EGP 9.44B
- Net income
- EGP 1.44B
- EBITDA
- EGP 2.46B
- Free cash flow
- EGP -109.98M
- Profit margin
- 15.27%
Balance sheet
- Total assets
- EGP 18.27B
- Total debt
- EGP 8.81B
- Book value
- EGP 6.24B
Growth
- Revenue growth
- 24.38%
- Profit growth
- 31.57%
- EPS growth
- 20.8%
Per share
- EPS (fiscal year)
- 8.9
- Book value per share
- 37
- Dividend per share
- 3.5
- Return on equity
- 26.46%
- Return on assets
- 8.57%
Technical
- RSI (14)
- 35.3
- 50-day moving average
- EGP 117.4
- 200-day moving average
- EGP 95.32
- Beta (1Y)
- 0.63
Shares
- Shares outstanding
- 168.76M
- Free float
- 31.64%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.